3-propoxy-pyrocatechol | 90673-85-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 3-propoxy-pyrocatechol
• 英文别名: 2.3-Dihydroxy-1-propyloxy-benzol；Propyl-(2.3-dihydroxy-phenyl)-aether；3-Propyloxy-brenzcatechin；1-O-Propyl-pyrogallol；3-Propoxy-brenzcatechin；3-Propoxybenzene-1,2-diol
• CAS: 90673-85-1
• 化学式: C₉H₁₂O₃
• 分子量: 168.192
• InChiKey: XCASKTQZYDNGCY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  溶剂黄146 、 alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 、 尿素 作用下， 生成 3-propoxy-pyrocatechol
  参考文献：
  名称：

  216.儿茶酚和邻苯三酚的某些衍生物。第二部分

  摘要：

  DOI：

  10.1039/jr9460001003

文献信息

• [EN] METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS<br/>[FR] PROCÉDÉ DE DÉSACYLATION ET/OU DE DÉSALKYLATION DE COMPOSÉS
  申请人：UNIV ANTWERPEN

  公开号：WO2019025535A1

  公开（公告）日：2019-02-07

  The present invention in general relates to a method for the deacylation and/or dealkylation (both O-dealkylation as well as C-dealkylation) of compounds, more specifically of aromatic compounds. The method is characterized by contacting the compound with an acid-containing aqueous reaction mixture using high temperature and high pressure conditions. The invention also provides a method for preparing a compound suitable for further deacylation using the method of the invention.

  本发明总体上涉及一种去酰化及/或脱烷基化（包括O-脱烷基化和C-脱烷基化）化合物的方法，更具体地说是芳香族化合物的方法。该方法的特点是在高温高压条件下，将化合物与含有酸的水性反应混合物接触。发明还提供了一种使用本发明方法进一步去酰化的合适化合物的制备方法。
• STABILIZATION OF HOUSEHOLD, BODY-CARE AND FOOD PRODUCTS BY USING BENZOTROPOLONE CONTAINING PLANT EXTRACTS AND/OR RELATED BENZOTROPOLONE DERIVATIVES
  申请人：Wagner Barbara

  公开号：US20120230925A1

  公开（公告）日：2012-09-13

  Disclosed is the use of benzotropolone derivatives of formula (1), wherein R 1 , R 2 and R 7 independently from each other are hydrogen; C 1 -C 3 alkyl; or COR 8 ; R 3 is hydrogen; or COOR 9 R 4 is hydrogen; or C 1 -C 3 alkyl; R 5 is hydrogen; hydroxy; C 1 -C 3 -alkoxy; or -0-(CO)—R 10 ; R 6 is hydrogen; C 1 -C 3 alkyl; or COR 8 ; or R 5 and R 6 together may form a five or six membered ring; or R 6 and R 7 together form a five or six membered ring; and R 8 , R 9 , R 10 independently of each other are C 1 -C 30 alkyl; for protecting body-care and household products from photolytic and oxidative degradation.

  本发明涉及一种使用化学式（1）中的苯并三酮衍生物的方法，其中R1、R2和R7分别独立地为氢原子；C1-C3烷基；或COR8；R3为氢原子；或COOR9；R4为氢原子；或C1-C3烷基；R5为氢原子；羟基；C1-C3-烷氧基；或-0-(CO)—R10；R6为氢原子；C1-C3烷基；或COR8；或R5和R6可以共同形成五元或六元环；或R6和R7可以共同形成五元或六元环；且R8、R9、R10分别独立地为C1-C30烷基；用于保护身体护理和家用产品免受光解和氧化降解的方法。
• Late transition metal catalysts for olefin polymerization and oligomerization
  申请人：Cherkasov Kuzunich Vladimir

  公开号：US20060047094A1

  公开（公告）日：2006-03-02

  This invention relates to a transition metal compound represented by the formula LMX wherein M is a Group 3 to 11 metal L is a bulky bidentate or tridentate neutral ligand that is bonded to M by two or three heteroatoms and at least one heteroatom is nitrogen; X is a substituted or unsubstituted catecholate ligand provided that the substituted catecholate ligand does not contain a 1,2-diketone functionality.

  本发明涉及一种由式LMX所表示的过渡金属化合物，其中M是第3到11族金属，L是一种笨重的双或三齿中性配体，通过两个或三个杂原子与M结合，至少一个杂原子是氮；X是一种取代或未取代的邻二酚配体，但取代的邻二酚配体不含1,2-二酮官能团。
• PREVENTIVES FOR ISCHEMIC HEART DISEASES
  申请人：TAISHO PHARMACEUTICAL CO. LTD

  公开号：EP0983764A1

  公开（公告）日：2000-03-08

  Preventives for post-complication and ischemic heart diseases characterized by containing as the active ingredient a compound represented by formula (I), which inhibits arterial plaque (intimal thickening) diabrosis in patients with arteriosclerosis to thereby prevent subsequent various ischemic diseases.

  用于并发症后和缺血性心脏病的预防剂，其特征在于含有由式（I）代表的化合物作为活性成分，该化合物可抑制动脉硬化患者的动脉斑块（内膜增厚）二坏死，从而预防随后的各种缺血性疾病。
• PREVENTIVES FOR RECONSTRICTION
  申请人：TAISHO PHARMACEUTICAL CO. LTD

  公开号：EP0983763A1

  公开（公告）日：2000-03-08

  This invention relates to an agent for preventing restenosis after coronary intervention therapy which comprises as an active ingredient a compound represented by the formula The agent for preventing restenosis according to the invention can provide a new use for preventing restenosis after coronary intervention therapy for the patients suffering from ischemic heart diseases who have severe stenosis or cannot be treated by a pharmacotherapy among those having a seizure of angina pectoris caused by stenosis of the coronary artery.

  本发明涉及一种用于预防冠状动脉介入治疗后再狭窄的制剂，其活性成分包括由 式表示的化合物 根据本发明的防止冠状动脉再狭窄的制剂可以为冠状动脉狭窄导致心绞痛发作的严重狭窄或药物疗法无法治疗的缺血性心脏病患者提供防止冠状动脉介入治疗后再狭窄的新用途。